PapersPMID:19821418
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Population, every finding
- adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
What moved
How to read these marks →“Treatment with coenzyme Q10 in subjects with systolic BP (SBP) > 140 mmHg or diastolic BP (DBP) > 90 mmHg resulted in mean decreases in SBP of 11 mmHg (95% CI 8, 14) and DBP of 7 mmHg (95% CI 5, 8).”
- Decreases systolic blood pressure
very limited
- Decreases diastolic blood pressure
very limited
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
- Participants
- 96
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 2